临床药师对支气管扩张合并药物性肝损伤患者的药学监护  

Pharmaceutical Care for Patient with Bronchiectasia and Drug Induced Liver Injury by Clinical Pharmacists

作　　者：于珊珊[1] 杜凤霞[1] 刘丽萍[1] 陈红鸽[1] 赵艳玲[1] 

机构地区：[1]解放军第302医院药学部,北京100039

出　　处：《中国医院用药评价与分析》2017年第1期16-17,21,共3页Evaluation and Analysis of Drug-use in Hospitals of China

基　　金：国家自然科学基金(No.81573631)

摘　　要：目的:探讨对支气管扩张合并药物性肝损伤肝患者实施药学监护的方法和意义。方法:对1例支气管扩张合并药物性肝损伤患者建立药历,进行用药分析,从支气管扩张、药物性肝损伤的治疗等方面提供药学监护,关注患者所用药物可能出现的药品不良反应,进行健康用药指导。结果:临床药师以用药选择、用法与用量、药品不良反应等方面为切入点,将药学理论与临床实践有机结合,为患者提供药学监护,提高了患者用药的安全性及有效性,促进了合理用药。结论:临床药师应发挥自身优势,协助医师制订用药方案,为患者提供精准的药学服务,为医师用药提供合理化建议。OBJECTIVE： To explore the approaches and significance of pharmaceutical care for patient with bronchiectasia and drug induced liver injury. METHODS： Medical records were established for a patient with bronchiectasia and drug induced liver injury, upon drug use analysis, pharmaceutical care was provided for bronchiectasia and drug induced liver injury. The possible adverse drug reactions（ ADR） were closely monitored,and health education was conducted. RESULTS： Using medication selection,dosage and usage and ADR as breakthrough point,combining pharmaceutical theory with clinical practice,clinical pharmacists provided pharmaceutical care for the patient so as to improve the safety and effectiveness medication and promote rational drug use. CONCLUSIONS：Clinical pharmacists play their own advantages to assist physicians in the formulation of medication programs,provide patients with precise pharmaceutical services and provide rational recommendations for the medication.

关 键 词：临床药师 支气管扩张 药物性肝损伤 药学监护 

分 类 号：R97[医药卫生—药品]